SODIUM SULAMYD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Sulamyd, and what generic alternatives are available?
Sodium Sulamyd is a drug marketed by Schering and is included in one NDA.
The generic ingredient in SODIUM SULAMYD is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Sulamyd
A generic version of SODIUM SULAMYD was approved as sulfacetamide sodium by SANDOZ on October 18th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SODIUM SULAMYD?
- What are the global sales for SODIUM SULAMYD?
- What is Average Wholesale Price for SODIUM SULAMYD?
Summary for SODIUM SULAMYD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 132 |
| Patent Applications: | 840 |
| DailyMed Link: | SODIUM SULAMYD at DailyMed |
US Patents and Regulatory Information for SODIUM SULAMYD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | SODIUM SULAMYD | sulfacetamide sodium | OINTMENT;OPHTHALMIC | 005963-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | SODIUM SULAMYD | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 005963-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | SODIUM SULAMYD | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 005963-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
